May 11 (Reuters)-
Haba Laboratories Inc
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Mar 31, 2023 Mar 31, 2022 Mar 31, 2024 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 12.04 12.91 13.50
(-6.7 pct) (+12.1 pct)
Operating loss 609 mln loss 316 mln 390 mln
Recurring loss 582 mln loss 292 mln 400 mln
Net
Net loss 707 mln loss 269 mln 250 mln
EPS loss 187.19 yen loss 71.14 yen 66.11 yen
Ann Div 40.00 yen 40.00 yen 40.00 yen
-Q2 Div NIL NIL NIL
-Q4 Div 40.00 yen 40.00 yen 40.00 yen
NOTE - Haba Laboratories Inc.
*Second Net profit row denotes profit attributable to owners ofthe parent
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4925.T